Karolinska Development expands its portfolio through new investment in AnaCardio
Stockholm, Sweden – June 17, 2021 Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the company has acquired approximately 21 percent of the shares in AnaCardio AB. The new portfolio company develops drugs for the treatment of heart failure, based on groundbreaking research from Karolinska Institutet. The company’s most advanced project is deemed to […]